Skip to main content

What’s new on emerging resistant Candida species

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Bassetti M, Garnacho-Montero J, Calandra T et al (2017) Intensive Care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med 43:1225–1238. https://doi.org/10.1007/s00134-017-4731-2

    Article  CAS  PubMed  Google Scholar 

  2. 2.

    Maubon D, Garnaud C, Calandra T et al (2014) Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? Intensive Care Med 40:1241–1255. https://doi.org/10.1007/s00134-014-3404-7

    Article  CAS  PubMed  Google Scholar 

  3. 3.

    Alexander BD, Johnson MD, Pfeiffer CD et al (2013) Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56:1724–1732. https://doi.org/10.1093/cid/cit136

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Pfaller MA, Castanheira M, Lockhart SR et al (2012) Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 50:1199–1203. https://doi.org/10.1128/JCM.06112-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Pham CD, Iqbal N, Bolden CB et al (2014) Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance. Antimicrob Agents Chemother 58:4690–4696. https://doi.org/10.1128/AAC.03255-14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Klotz U, Schmidt D, Willinger B et al (2016) Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria. Mycoses 59:312–318. https://doi.org/10.1111/myc.12472

    Article  CAS  PubMed  Google Scholar 

  7. 7.

    Marcos-Zambrano LJ, Escribano P, Sanchez C et al (2014) Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center. Antimicrob Agents Chemother 58:4565–4572. https://doi.org/10.1128/AAC.02670-14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Delliere S, Healey K, Gits-Muselli M et al (2016) Fluconazole and echinocandin resistance of candida glabrata correlates better with antifungal drug exposure rather than with MSH2 mutator genotype in a french cohort of patients harboring low rates of resistance. Front Microbiol 7:2038. https://doi.org/10.3389/fmicb.2016.02038

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Scapaticci M, Bartolini A, Del Chierico F et al (2018) Phenotypic typing and epidemiological survey of antifungal resistance of Candida species detected in clinical samples of Italian patients in a 17 months’ period. Germs 8:58–66. https://doi.org/10.18683/germs.2018.1132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Castanheira M (2018) Fungemia surveillance in Denmark demonstrates emergence of non-albicans Candida species and higher antifungal usage and resistance rates than in other nations. J Clin Microbiol 56:e01907–e01917. https://doi.org/10.1128/JCM.01907-17

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Singh A, Healey KR, Yadav P et al (2018) Absence of azole or echinocandin resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in the DNA mismatch repair pathway. Antimicrob Agents Chemother. https://doi.org/10.1128/AAC.00195-18

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Perlin DS (2015) Echinocandin resistance in Candida. Clin Infect Dis 61(Suppl 6):S612–S617. https://doi.org/10.1093/cid/civ791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Arendrup MC, Patterson TF (2017) Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis 216:S445–S451. https://doi.org/10.1093/infdis/jix131

    Article  CAS  PubMed  Google Scholar 

  14. 14.

    Shields RK, Nguyen MH, Clancy CJ (2015) Clinical perspectives on echinocandin resistance among Candida species. Curr Opin Infect Dis 28:514–522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Schell WA, Jones AM, Borroto-Esoda K, Alexander BD (2017) Antifungal activity of SCY-078 and standard antifungal agents against 178 clinical isolates of resistant and susceptible Candida species. Antimicrob Agents Chemother 62:e00195-18. https://doi.org/10.1128/AAC.01102-17

    Article  Google Scholar 

  16. 16.

    Kohlenberg A, Struelens MJ, Monnet DL, Plachouras D (2018) Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017. Euro Surveill. https://doi.org/10.2807/1560-7917.ES.2018.23.13.18-00136

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Chowdhary A, Sharma C, Meis JF (2017) Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog 13:e1006290. https://doi.org/10.1371/journal.ppat.1006290

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. 18.

    https://www.cdc.gov/fungal/diseases/candidiasis/tracking-c-auris.html. Accessed 6 May 2018

  19. 19.

    Lockhart SR, Etienne KA, Vallabhaneni S et al (2017) Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64:134–140. https://doi.org/10.1093/cid/ciw691

    Article  CAS  PubMed  Google Scholar 

  20. 20.

    Ku TSN, Walraven CJ, Lee SA (2018) Candida auris: disinfectants and implications for infection control. Front Microbiol 9:726. https://doi.org/10.3389/fmicb.2018.00726

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Kordalewska M, Lee A, Park S et al (2018) Understanding echinocandin resistance in the emerging pathogen Candida auris. Antimicrob Agents Chemother 62:e00238-18. https://doi.org/10.1128/AAC.00238-18

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Chowdhary A, Prakash A, Sharma C et al (2018) A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–2017) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother 73:891–899. https://doi.org/10.1093/jac/dkx480

    Article  CAS  PubMed  Google Scholar 

  23. 23.

    Hager CL, Larkin EL, Long LA, Ghannoum MA (2018) Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model. J Antimicrob Chemother 73:2085–2088. https://doi.org/10.1093/jac/dky153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Andrea Cortegiani.

Ethics declarations

Conflicts of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cortegiani, A., Misseri, G. & Chowdhary, A. What’s new on emerging resistant Candida species. Intensive Care Med 45, 512–515 (2019). https://doi.org/10.1007/s00134-018-5363-x

Download citation

Keywords

  • Echinocandin Resistance
  • Candida Auris
  • Aural Infection
  • Glabrata
  • Isavuconazole